DIONOSIL AQUEOUS Drug Patent Profile
✉ Email this page to a colleague
When do Dionosil Aqueous patents expire, and what generic alternatives are available?
Dionosil Aqueous is a drug marketed by Glaxosmithkline and is included in one NDA.
The generic ingredient in DIONOSIL AQUEOUS is propyliodone. Additional details are available on the propyliodone profile page.
Summary for DIONOSIL AQUEOUS
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 37 |
Patent Applications: | 542 |
DailyMed Link: | DIONOSIL AQUEOUS at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for DIONOSIL AQUEOUS
US Patents and Regulatory Information for DIONOSIL AQUEOUS
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Glaxosmithkline | DIONOSIL AQUEOUS | propyliodone | SUSPENSION;INTRATRACHEAL | 009309-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |